Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CTNNB1 |
| Variant | mutant |
| Impact List | unknown |
| Protein Effect | unknown |
| Gene Variant Descriptions | CTNNB1 mutant indicates an unspecified mutation in the CTNNB1 gene. |
| Associated Drug Resistance | |
| Category Variants Paths |
CTNNB1 mutant |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06811116 | Phase Ib/II | Cabozantinib Cabozantinib + Sapanisertib | Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein Beta-Catenin, The SAPHIRE Trial | Recruiting | USA | 0 |